David H. Bollinger

Array ( [id] => 1357123 [patent_doc_number] => 06573050 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma' [patent_app_type] => B1 [patent_app_number] => 09/697074 [patent_app_country] => US [patent_app_date] => 2000-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 10698 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573050.pdf [firstpage_image] =>[orig_patent_app_number] => 09697074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150328 [patent_doc_number] => 06770633 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'Ribozyme therapy for the treatment of proliferative skin and eye diseases' [patent_app_type] => B1 [patent_app_number] => 09/696791 [patent_app_country] => US [patent_app_date] => 2000-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 12034 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770633.pdf [firstpage_image] =>[orig_patent_app_number] => 09696791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1371575 [patent_doc_number] => 06566514 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth' [patent_app_type] => B1 [patent_app_number] => 09/601144 [patent_app_country] => US [patent_app_date] => 2000-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 28 [patent_no_of_words] => 14671 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566514.pdf [firstpage_image] =>[orig_patent_app_number] => 09601144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1271749 [patent_doc_number] => 06653467 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Medicament for treatment of Duchenne muscular dystrophy' [patent_app_type] => B1 [patent_app_number] => 09/667327 [patent_app_country] => US [patent_app_date] => 2000-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9399 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653467.pdf [firstpage_image] =>[orig_patent_app_number] => 09667327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1269855 [patent_doc_number] => 06653133 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Antisense modulation of Fas mediated signaling' [patent_app_type] => B1 [patent_app_number] => 09/665615 [patent_app_country] => US [patent_app_date] => 2000-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42046 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653133.pdf [firstpage_image] =>[orig_patent_app_number] => 09665615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1310042 [patent_doc_number] => 06613567 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Antisense inhibition of Her-2 expression' [patent_app_type] => B1 [patent_app_number] => 09/663834 [patent_app_country] => US [patent_app_date] => 2000-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27198 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613567.pdf [firstpage_image] =>[orig_patent_app_number] => 09663834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446455 [patent_doc_number] => 06368856 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Antisense inhibition of Phosphorylase kinase beta expression' [patent_app_type] => B1 [patent_app_number] => 09/662250 [patent_app_country] => US [patent_app_date] => 2000-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31426 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368856.pdf [firstpage_image] =>[orig_patent_app_number] => 09662250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380167 [patent_doc_number] => 06277636 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Antisense inhibition of MADH6 expression' [patent_app_type] => 1 [patent_app_number] => 9/662249 [patent_app_country] => US [patent_app_date] => 2000-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28206 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277636.pdf [firstpage_image] =>[orig_patent_app_number] => 662249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560142 [patent_doc_number] => 06436909 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Antisense inhibition of transforming growth factor- expression' [patent_app_type] => B1 [patent_app_number] => 09/661753 [patent_app_country] => US [patent_app_date] => 2000-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22391 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436909.pdf [firstpage_image] =>[orig_patent_app_number] => 09661753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474256 [patent_doc_number] => 06387699 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Antisense inhibition of A20 expression' [patent_app_type] => B1 [patent_app_number] => 09/658687 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24827 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387699.pdf [firstpage_image] =>[orig_patent_app_number] => 09658687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549516 [patent_doc_number] => 06346416 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Antisense inhibition of HPK/GCK-like kinase expression' [patent_app_type] => B1 [patent_app_number] => 09/651011 [patent_app_country] => US [patent_app_date] => 2000-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27814 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346416.pdf [firstpage_image] =>[orig_patent_app_number] => 09651011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059445 [patent_doc_number] => 06852535 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Polymerase III-based expression of therapeutic RNAS' [patent_app_type] => utility [patent_app_number] => 09/630846 [patent_app_country] => US [patent_app_date] => 2000-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 9150 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852535.pdf [firstpage_image] =>[orig_patent_app_number] => 09630846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241107 [patent_doc_number] => 06682930 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Triplex forming oligonucleotides and their use in anti-HBV' [patent_app_type] => B1 [patent_app_number] => 09/529812 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 8517 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682930.pdf [firstpage_image] =>[orig_patent_app_number] => 09529812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342269 [patent_doc_number] => 06586391 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Method of ameliorating erectile dysfunction' [patent_app_type] => B1 [patent_app_number] => 09/618477 [patent_app_country] => US [patent_app_date] => 2000-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7761 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586391.pdf [firstpage_image] =>[orig_patent_app_number] => 09618477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209150 [patent_doc_number] => 06713302 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Growth differentiation factor-6' [patent_app_type] => B1 [patent_app_number] => 09/619061 [patent_app_country] => US [patent_app_date] => 2000-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10400 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713302.pdf [firstpage_image] =>[orig_patent_app_number] => 09619061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009424 [patent_doc_number] => 06900186 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-31 [patent_title] => 'Method for the prophylaxis and/or treatment of medical disorders' [patent_app_type] => utility [patent_app_number] => 09/598274 [patent_app_country] => US [patent_app_date] => 2000-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 52 [patent_no_of_words] => 32307 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900186.pdf [firstpage_image] =>[orig_patent_app_number] => 09598274 [rel_patent_id] =>[rel_patent_doc_number] =>)